Positive Effects of Preventive Nutrition Supplement on Anticancer Radiotherapy in Lung Cancer Bearing Mice

CCUR > College of Natural Science and Engineering > College of Science > Department of Biology > journal articles > Item 987654321/48771

Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/48771

Title:	Positive Effects of Preventive Nutrition Supplement on Anticancer Radiotherapy in Lung Cancer Bearing Mice
Authors:	Liu, YM (Liu, Yu-Ming) Wu, TH (Wu, Tsung-Han) Chiu, YH (Chiu, Yi-Han) Wang, H (Wang, Hang) Li, TL (Li, Tsung-Lin) Hsia, SM (Hsia, Simon) Chan, YL (Chan, Yi-Lin) Wu, CJ (Wu, Chang-Jer)
Contributors:	生科系
Keywords:	nutrition preventive supplement radiotherapy lung cancer sarcopenia inflammation EGFR Bcl-2 VEGF PD-L1
Date:	2020-09
Issue Date:	2020-11-03 10:32:09 (UTC+8)
Abstract:	Simple Summary The supplement of TNuF, a total nutrition formula, before cancer diagnosis significantly enhanced the anticancer effect of radiotherapy against primary tumor and lung metastasis in tumor-bearing mice. Meanwhile, TNuF improved cancer related sarcopenia. We supposed that these benefits are related to the regulations of cell proliferation, angiogenesis, and immunity in tumor microenvironment. (1)Background: Radiotherapy (RT) is one of the major treatments for non-small cell lung cancer, but RT-associated toxicities usually impede its anticancer effect. Nutrient supplementation has been applied for cancer prevention or a complementary measure to anticancer therapy. Here, we explored the influence of total nutrition supplementation before and after cancer occurrence on the anticancer benefit and side effects of RT. (2)Methods: C57BL/6JNarl mice were inoculated with Lewis lung carcinoma cells and then treated with radiotherapy. TNuF, a total nutrition formula, was prescribed by oral gavage. In the preventive groups, TNuF supplementation started from seven days before tumor inoculation. In the complementary groups, TNuF supplementation began after tumor inoculation. (3)Results: TNuF successfully enhanced the anticancer effect of RT against primary tumor and lung metastasis. Additionally, the complementary supplement improved the high serum TNF-alpha level and the wasting of sartorius muscle in mice receiving RT. In histologic and molecular analysis, TNuF was observed to modulate EGFR, apoptosis, and VEGF and PD-1/PD-L1 pathways. Furthermore, the anticancer benefit of the preventive supplement was comparable to that of the complementary administration. (4)Conclusions: Our results demonstrated that the prescription of the TNuF total nutrition formula before and after cancer diagnosis attains similar benefits in testing subjects with typical anticancer RT. TNuF is also a potential sensitizer to anti-PD-1 immune therapy.
Relation:	CANCERS 卷冊: 12 期: 9 文獻號碼: 2445
Appears in Collections:	[Department of Biology ] journal articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	176	View/Open

View Licence

Loading...